Patent · US Active

Stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof

US9867829B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Sandoz AG · CH

Inventors

Franz Schwarz · Feldbach, AT
Georg Anker · Kundl, AT
Johann Bacher · Kundl, AT
Andreas Hotter · Kundl, AT

Key dates

Filing date	Aug 12, 2013
Grant date	Jan 16, 2018
Priority date	—
Expiry date	Aug 12, 2033

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB65D2565/388
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate, processes for preparing the stable pharmaceutical composition, and a container comprising the stable pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.